Rhythm Pharmaceuticals (RYTM) vs TG Therapeutics (TGTX)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.
Summary
TG Therapeutics (TGTX) has outperformed Rhythm Pharmaceuticals (RYTM) over the past year, gaining 98.2% versus a gain of 10.4%. Over five years, RYTM leads with a +1116.0% price change compared with +164.1% for TGTX. TG Therapeutics is the larger company by market cap ($9.57 billion vs $7.79 billion), about 1.2 times the size.
TG Therapeutics converts more of its revenue into profit, with a net margin of 72.6% versus -103.6%.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | RYTM | TGTX |
|---|---|---|
| Share price | $112.36 | $63.34 |
| Market cap | $7.79B | $9.57B |
| 1-day change | -3.80% | -2.37% |
| YTD return | +4.97% | +112.48% |
| 1-year return | +10.44% | +98.25% |
| 5-year return | +1116.02% | +164.14% |
| P/E ratio (TTM) | — | 94.54 |
| Forward P/E | — | 24.81 |
| EPS (TTM) | $-2.91 | $0.67 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | $189.76M | $616.29M |
| Revenue growth (YoY) | +45.83% | +87.32% |
| Net income (latest FY) | $-196.54M | $447.18M |
| Gross margin | 89.73% | 83.66% |
| Operating margin | -101.19% | 20.01% |
| Net margin | -103.57% | 72.56% |
| 52-week high | $122.20 | $68.03 |
| 52-week low | $74.50 | $26.76 |
| Distance from 52-week high | -8.05% | -6.89% |
| Analyst consensus | strong_buy | strong_buy |
| Avg. price target upside | +24.71% | +9.61% |
| Average volume | 1.10M | 1.86M |
| Shares outstanding | 69.33M | 151.15M |
| Employees | 414 | 399 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- TGTX has outperformed RYTM by 87.8 percentage points over the past year.
- TG Therapeutics is more profitable, keeping 72.6 cents of every revenue dollar as net income versus -103.6 cents for Rhythm Pharmaceuticals.
- TG Therapeutics grew revenue faster in its latest fiscal year (+87.32% vs +45.83%).
About Rhythm Pharmaceuticals
RYTM stock →Rhythm Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the rare neuroendocrine diseases in the United States and internationally. The company's lead product candidate is IMCIVREE (setmelanotide), a rare melanocortin-4 receptor for the treatment of pro-opiomelanocortin (POMC), proprotein convertase subtilisin/kexin type 1, leptin receptor (LEPR) deficiency obesity, Bardet-Biedl and Alström syndrome, Prader-Willi syndrome, and hypothalamic obesity.
Health Care · Biotechnology: Pharmaceutical Preparations · 414 employees
About TG Therapeutics
TGTX stock →TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell mediated diseases in the United States and internationally. The company provides BRIUMVI, an anti-CD20 monoclonal antibody for the treatment of adult patients with relapsing forms of multiple sclerosis (RMS), including clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease in adults.
Health Care · Biotechnology: Pharmaceutical Preparations · 399 employees
RYTM vs TGTX FAQ
Which is bigger, Rhythm Pharmaceuticals or TG Therapeutics?
TG Therapeutics (TGTX) is larger, with a market capitalization of $9.57B compared with $7.79B for Rhythm Pharmaceuticals (RYTM).
Which stock has performed better over the past year, RYTM or TGTX?
TGTX returned +98.25% over the past 12 months, compared with +10.44% for RYTM (price return, excluding dividends). Past performance does not predict future results.
Are Rhythm Pharmaceuticals and TG Therapeutics in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.